142 related articles for article (PubMed ID: 4055449)
1. Relationship between lymph nodal status and primary tumor control probability in tumors of the supraglottic larynx.
Wall TJ; Peters LJ; Brown BW; Oswald MJ; Milas L
Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1895-902. PubMed ID: 4055449
[TBL] [Abstract][Full Text] [Related]
2. The role of postradiotherapy neck dissection in supraglottic carcinoma.
Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
[TBL] [Abstract][Full Text] [Related]
3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
4. [The difference of larynx cancer stage evaluation between clinical and pathological examinations].
Wolny E; Idasiak A; Wydmański J; Miszczyk L
Otolaryngol Pol; 2006; 60(1):15-20. PubMed ID: 16821535
[TBL] [Abstract][Full Text] [Related]
5. [Patterns and prognostic factors of cervical lymph node metastasis in supraglottic laryngeal carcinoma].
Li X; Di B; Shao Y; Shang Y; Cheng J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 18(12):707-10. PubMed ID: 15831037
[TBL] [Abstract][Full Text] [Related]
6. [Systematic analysis of cervical lymph node metastasis of larynx and hypopharynx carcinomas--a clinical computerized tomography study with special reference to extension of the primary tumor].
Pfreundner L; Pahnke J; Desing A; Schindel M
Laryngorhinootologie; 1996 Oct; 75(10):602-10. PubMed ID: 9035664
[TBL] [Abstract][Full Text] [Related]
7. Clinical staging for primary malignancies of the supraglottic larynx.
Zamora RL; Harvey JE; Sessions DG; Spitznagel EL
Laryngoscope; 1993 Jan; 103(1 Pt 1):69-77. PubMed ID: 8421423
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Xie M; Sun Y; Li Y
Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
[TBL] [Abstract][Full Text] [Related]
9. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
[TBL] [Abstract][Full Text] [Related]
10. 331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach.
Sykes AJ; Slevin NJ; Gupta NK; Brewster AE
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1109-15. PubMed ID: 10725620
[TBL] [Abstract][Full Text] [Related]
11. Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy?
Rudoltz MS; Benammar A; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):503-8. PubMed ID: 7852112
[TBL] [Abstract][Full Text] [Related]
12. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
13. [Impact of extracapsular lymph node spread in the ipsilateral neck on contralateral neck metastasis and prognosis of laryngeal cancer].
Liu B; Guan C; Ji WY; Pan ZM
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):871-5. PubMed ID: 17416015
[TBL] [Abstract][Full Text] [Related]
14. [Neck relapse-related factors of cN0 stage supraglottic cancer].
Yu WB; Zeng ZY; Chen FJ; Zhang Q
Ai Zheng; 2006 Mar; 25(3):355-8. PubMed ID: 16536994
[TBL] [Abstract][Full Text] [Related]
15. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
[TBL] [Abstract][Full Text] [Related]
16. Recurrence after radiotherapy for glottic carcinoma.
Viani L; Stell PM; Dalby JE
Cancer; 1991 Feb; 67(3):577-84. PubMed ID: 1898708
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of lymph node involvement in pyriform sinus and supraglottic cancers.
Hahn SS; Spaulding CA; Kim JA; Constable WC
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1143-7. PubMed ID: 3610702
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
19. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
